key: cord-0872863-egnuhzma
authors: Elibol, Elif; Koçak, Özgenur; Sancak, Mecit; Arslan, Bengi; Gül, Fatih; Babademez, Mehmet Ali
title: The effect of COVID-19 pandemic on laryngeal cancer in a tertiary referral center
date: 2022-01-15
journal: Eur Arch Otorhinolaryngol
DOI: 10.1007/s00405-022-07268-z
sha: 0207adf5e83b19294e6a66cf73231d842fe819c1
doc_id: 872863
cord_uid: egnuhzma

PURPOSE: This study aimed to evaluate whether there was a significant change in the laryngeal cancer stage before and after the COVID-19 pandemic. METHODS: This retrospective cohort study was conducted to evaluate the data of patients who operated due to laryngeal cancer in a tertiary referral hospital’s ear, nose, and throat (ENT) department between June 2018 and 2021. The patients were included at the same period of the years to rule out any seasonal changes. The basic characteristic, tumor localization, and TNM stage of the patients were compared. RESULTS: 97 patients were operated due to laryngeal cancer during the time period reviewed. 57 (58.8%) patients were operated before and 40 (41.2%) after the COVID-19 pandemic. When comparing the patients before and after the COVID-19 pandemic period, the mean age significantly differed between the study groups that older age was observed in patients who admitted before the COVID-19 pandemic (62.8 ± 6.5 vs. 57.3 ± 6.8, p < 0.001). Regarding the TNM classification, the patients in the after COVID-19 pandemic group had higher rates of T4 stage laryngeal cancer compared to before COVID-19 pandemic group (12 (30%) vs. 4 (7%), p: 0.003). CONCLUSION: Younger patients have operated after the COVID-19 pandemic, and the patients were presented with larger tumor sizes. The pandemic may increase the time between diagnosis and surgery in laryngeal cancer patients.

The COVID-19 disease was first observed in the Republic of China at the end of December 2019, and it was declared a pandemic by the World Health Organization (WHO) on March 11, 2020 [1] . Consequently, curfew measures, travel restrictions, and social distancing are accepted as the'' new normal'' of daily life. Moreover, routine health services were limited, and surgeries were canceled except for emergency and oncological cases [2] . These alterations made it difficult for cancer patients to reach healthcare facilities resulting in delays in scheduled appointments and diagnosis of the patients with laryngeal or oropharyngeal cancer [3, 4] .

During this period, associations published recommendations on managing patients with head and neck cancer [5] [6] [7] . Accordingly, it was suggested that patients should be guided by triage to use the existing equipment effectively, and the severity of cancer should be determined as soon as possible [8] . At the same time, it was aimed to protect ear, nose, and throat (ENT) surgeons from transmission risk of the virus during orolaryngeal procedures such as tracheostomy or mucosal resections.

Studies from different countries have been conducted to evaluate the risk of delays in the diagnosis and treatment of head and neck cancers during this period. The common result of these studies was that the disease stage was significantly advanced in patients admitted after COVID-19 restrictions [8] . However, there is a lack of evidence regarding the tumor stage of the patients in our country with laryngeal cancer.

This study aimed to reveal whether there was a significant change in cancer stage in patients who were operated laryngeal cancer before and after COVID-19 lockdown in a high-volume tertiary referral center. 

This retrospective cohort study was conducted to evaluate the data of patients who operated due to laryngeal cancer in a tertiary referral hospital's ENT department between June 2018 and June 2021. The institutional ethical approval was obtained before data collection (approval number 2021/E2-21-898). The patients were included at the same period of the years to rule out any seasonal changes. The basic characteristic, tumor localization, and TNM stage of the patients were compared.

The data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 23. The data were presented as mean, standard deviation, frequency, and percentages. (Table 1) . When comparing the patients before and after the COVID-19 pandemic, the mean age significantly differed between the study groups that older age was observed in patients admitted before COVID-19 pandemic (62.8 ± 6.5 vs. 57.3 ± 6.8, p < 0.001). No difference was observed regarding gender and the area of involvement between the study groups. Regarding the TNM classification, the patients in the after COVID-19 pandemic group had higher rates of T4 stage laryngeal cancer compared to before the COVID-19 pandemic group (12 (30%) vs. 4 (7%), p: 0.003). No significant difference was observed considering other TNM stages between the study groups ( Table 2 ).

This study revealed that younger patients with larger tumors were operated after the COVID-19 pandemic.

According to the previous studies, a crucial decrease was observed in outpatient and surgical services in the time period between 9th March and 20th April 2020 in otolaryngology departments [9] . A 10% decrease was observed in oncological cases despite allowance in emergency and oncologic procedures [9] . This decrease could be related to the fear of hospital-related contamination and the shortage of healthcare services. In another study, the number of patients dropped from 4993 to 556 cases despite allowance in emergency and cancer patients during the pandemic. The decrease in elective cases also caused a reduction in the number of diagnostic procedures in cancer suspected patients [10] . Laccourreye et al. reported a 10.9% reduction in ENT oncological activities. The number of cancer patients varied between 75.8 and 79%, and no significant differences were observed in cancer diagnosis before and after the COVID-19 period [8] . Besides, there was no significant difference between the time period before and after pandemic regarding surgical technique, postoperative course, intensive care, or hospital stay [8] . Regarding the tumor stage, T3/4 and N2/3 tumors were more frequent after COVID-19 pandemic (p: 0.002 and 0.0004, respectively). The authors concluded a limited impact of the COVID-19 pandemic on surgical diagnosis and cancer surgery in their otorhinolaryngology department [8] . Murri et al. evaluated the numbers of laryngeal SCC patients during the pandemic and compared them with the patients attended before the pandemic [11] . The authors concluded that there were 19 laryngeal cancers in the postpandemic group and 25 patients in the before the pandemic group. No significant differences were observed regarding the tumor stage between the study groups. However, they reported an increase in the time between cancer diagnosis and surgical treatment [11] .

In our study, there was 57 patients before the pandemic and 40 patients after the pandemic group, which lower admission was observed after the pandemic period. Besides, the younger patients with laryngeal cancer were mostly admitted to the hospital after the pandemic. These results could be related that the older patients might be keen to stay away from the hospitals due to fear of COVID-19 infection. Regarding the TNM classification results after the COVID-19 pandemic group had higher T4 stage cancer than the before COVID-19 pandemic group. We may speculate that the delays in the diagnosis and appointments could lead to late diagnosis of the patients with laryngeal cancer.

The strengths of our study are the number of patients who admitted to a tertiary referral hospital and the first study that present the results of this issue in our country. The limitation of our study is its retrospective nature that could increase the risk of bias.

In conclusion, the time between cancer diagnosis and surgery might increase during the pandemic due to the lack of the medical and health care providers. An effective appointment system, telemedicine, or priority for cancer patients could decrease the delays in a unit dealing with laryngeal cancers.

Funding None.

Ethics approval This study was approved by the local ethics committee (approval no: 2021/E2-21-898) and conducted in concordance with Helsinki declaration and good clinical practice guidelines. 

Unlocking towns and cities: COVID-19 exit strategy

Impact of the COVID-19 lockdown on basic science research in ophthalmology: the 160 Craniomaxillofacial Trauma & Reconstruction 14(2) experience of a highly specialized research facility in France

Covid-19: collateral damage of lockdown in India

Global epidemiology of head and neck cancers: a continuing challenge

Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019-2020: Sichuan cancer hospital

Surgical management of head and neck tumours during the SARS-CoV (Covid-19) pandemic

Role and management of a head and neck department during the COVID-19 outbreak in Lombardy

Impact of the first month of Covid-19 lockdown on oncologic surgical activity in the Ile de France region university hospital otorhinolaryngology departments

Impact of COVID-19 pandemic on Italian otolaryngology units: a nationwide study

Impact of COVID-19 on management of laryngeal/oropharyngeal neoplasms

Reduction in healthcare services during the COVID-19 pandemic: Patient screening based on symptoms is an effective strategy for avoiding delayed laryngeal cancer diagnosis

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations